PROPE Severe Asthma Study in Egypt
Conditions: Severe Asthma Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.
Conditions: Non Small Cell Lung Cancer Interventions: Drug: Adjuvant durvalumab Sponsors: ETOP IBCSG Partners Foundation; AstraZeneca AG Switzerland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
C.Difficile Observational Study
Conditions: Clostridium Infections Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
Long-term Effect of Steroid on Metabolic Diseases in Asthmatics
Conditions: Asthma; Osteoporosis, Osteopenia; Osteoporosis Risk; Osteoporotic Fractures Interventions: Drug: Corticosteroid Sponsors: Ajou University School of Medicine; AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
Screen CardRen - A Cross-sectional Observational Cohort Study
Conditions: Heart Failure; Chronic Kidney Diseases Interventions: Diagnostic Test: Echocardiography Sponsors: Charite University, Berlin, Germany; AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
A Study of T-DXd in Patients With Selected HER2-overexpressing Tumors
Conditions: Advanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer) Interventions: Drug: Trastuzumab deruxtecan Sponsors: AstraZeneca; Daiichi Sankyo Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCK
Conditions: Liver Cirrhosis Interventions: Drug: Placebo (placebo matching zibotentan capsule and placebo matching dapagliflozin tablet); Drug: Zibotentan + placebo (placebo matching dapagliflozin tablet); Drug: Zibotentan + dapagliflozin Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.
Conditions: Chronic Kidney Disease and Hypertension Interventions: Drug: Baxdrostat/dapagliflozin; Drug: Dapagliflozin in combination with placebo Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Conditions: Metastatic Prostate Cancer Interventions: Biological: AZD0754 Sponsors: AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
A Retrospective Chart Review to Investigate Clinical Remission in Patients With Severe Asthma Treated With Biologics in the United Kingdom National Health Service
Conditions: Asthma Interventions: Drug: Biologic treatment Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials
Pediatric Readiness Intervention in Manitoba
Conditions: Pediatric Readiness Interventions: Other: Education and training Sponsors: University of Manitoba; Manitoba Medical Service Foundation; Children ' s Hospital Research Institute of Manitoba; AstraZeneca Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
Observational Study Protocol: LIVER-R
Conditions: Hepatobiliary Cancers Interventions: Other: Durvalumab-based combination therapies in observational study setting; Other: Durvalumab-based combination therapies in observational study setting Sponsors: AstraZeneca; ICON plc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma
Conditions: Asthma, Exercise-Induced Interventions: Drug: Budesonide/albuterol metered-dose inhaler 160/180 μg; Drug: Placebo metered-dose inhaler Sponsors: AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic Alterations
Conditions: Non-small-cell Lung Cancer Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
A Study to Assess Multidomain Endpoints of an ECG Patch
Conditions: Acute Decompensated Heart Failure Interventions: Device: ECG Patch Sponsors: AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
